Dupont Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Dupont Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,734	Closed	-$275K	–	1855
2021 Q2	$275K	Hold	2,734	–	–	0.01%	1228
2021 Q1	$255K	Sell	2,734 -561	-17%	-$56.9K	0.01%	1198
2020 Q4	$272K	Buy	3,295 +1,475	+81%	+$126K	0.01%	1063
2020 Q3	$156K	Sell	1,820 -8,054	-82%	-$939K	﹤0.01%	1151
2020 Q2	$918K	Buy	+9,874	New	+$544K	0.02%	550

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dupont Capital Management's VBIV Position: Q3 2021 in Review

Dupont Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2021, closing a stake of 2,734 shares — an estimated $275K sold.

Dupont Capital Management first reported a position in VBIV in Q2 2020 and held it in 5 quarters. The position peaked at $918K in Q2 2020. 126 funds tracked by Wall St. Rank hold VBIV as of Q3 2021.

Dupont Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2021 after selling out during the quarter.
Dupont Capital Management sold 2,734 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2021, an estimated $275K.
Dupont Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 5 quarters.
Dupont Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $918K in Q2 2020.
126 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2021.

Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.